Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Issa Khouri
Autologous Stem Cell Transplantation for Refractory or Poor-Risk Relapsed Hodgkin's Lymphoma: Effect of the Specific High-Dose Chemotherapy Regimen on Outcome
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Clinical Outcomes and Prognostic Factors in Patients With Richter's Syndrome Treated With Chemotherapy or Chemoimmunotherapy With or Without Stem-Cell Transplantation
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Related publications
Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin's Lymphoma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Mitoxantrone-Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Relapsed/Refractory Lymphoma
Turkish Journal of Medical Sciences
Medicine
LACE-conditioned Autologous Stem Cell Transplantation for Relapsed or Refractory Hodgkin's Lymphoma: Treatment Outcome and Risk Factor Analysis in 67 Patients From a Single Centre
Bone Marrow Transplantation
Transplantation
Hematology
Infections Following Autologous Stem Cell Transplantation for Hodgkin'S Lymphoma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Phase I Dose-Escalation Study of Venetoclax Plus Beam Followed by Autologous Stem Cell Transplant (Asct) for Chemoresistant, Relapsed/Refractory, or High-Risk Non-Hodgkin's Lymphoma (Nhl); Preliminary Results
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Outcome of Patients With Aggressive B-Cell Lymphoma Who Failed to Proceed to or Relapsed After High Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Brentuximab Vedotin Salvage Followed by Consolidation Post Autologous Hematopoietic Stem Cell Transplantation in High Risk Relapsed Refractory Hodgkin Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
High-Dose Chemotherapy (HDC) and Autologous Hematopoietic Stem Cell Transplantation (ASCT) as Salvage Therapy for Relapsed Osteosarcoma
Bone Marrow Transplantation
Transplantation
Hematology
Outcomes of Autologous Stem Cell Transplantation (ASCT) in Patients With Relapsed/Refractory HIV-associated Lymphoma
Bone Marrow Transplantation
Transplantation
Hematology
